Cathepsin K, Osteoclastic Resorption, and Osteoporosis Therapy-Reference-Cited by-同舟云学术

Cathepsin K, Osteoclastic Resorption, and Osteoporosis Therapy

Published:2001-10-01 Issue:10 Volume:16 Page:1747-1749
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Zaidi Mone,Troen Bruce,Moonga Baljit S.,Abe Etsuko

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference33 articles.

1. Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a non-human primate;Stroup;J Bone Miner Res,2001

2. The collagenolytic activity of cathepsin K is unique among mammalian proteinases;Garnero;J Biol Chem,1998

3. Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts;Vaes;Clin Orthop,1988

4. Molecular mechanisms of bone resorption by the osteoclast;Baron;Anat Rec,1989

5. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency;Gelb;Science,1996

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel selective proline-based peptidomimetics for human cathepsin K inhibition;Bioorganic & Medicinal Chemistry Letters;2024-09

2. Lysosomal biogenesis and function in osteoclasts: a comprehensive review;Frontiers in Cell and Developmental Biology;2024-08-07

3. The Hippo kinases control inflammatory Hippo signaling and restrict bacterial infection in phagocytes;mBio;2024-05-08

4. Redox signaling and antioxidant defense in osteoclasts;Free Radical Biology and Medicine;2024-02

5. The Hippo kinases control inflammatory Hippo signaling and restrict bacterial infection in eukaryotic phagocytes;2023-12-08